We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Marqeta
MQ
$1.8B
| $22.2K | ﹤0.01% |
1,363
+208
| +18% | +$3.5K |
|
1927
CareDx
CDNA
$1.92B
| $22.2K | ﹤0.01% |
1,278
+360
| +39% | +$6.81K |
|
1928
FIVE9
FIVN
$1.77B
| $22.2K | ﹤0.01% |
1,462
+457
| +45% | +$7.94K |
|
1929
Standard Motor Products
SMP
$861M
| $22K | ﹤0.01% |
634
+251
| +66% | +$9.91K |
|
1930
FIGS
FIGS
$1.59B
| $21.9K | ﹤0.01% |
1,482
+344
| +30% | +$4.41K |
|
1931
Coursera
COUR
$1.54B
| $21.9K | ﹤0.01% |
3,757
+1,359
| +57% | +$8.48K |
|
1932
CBIZ
CBZ
$2.29B
| $21.8K | ﹤0.01% |
813
+175
| +27% | +$6.17K |
|
1933
John Wiley & Sons Class A
WLY
$2.52B
| $21.8K | ﹤0.01% |
571
+110
| +24% | +$3.56K |
|
1934
The RealReal
REAL
$1.34B
| $21.7K | ﹤0.01% |
2,392
+786
| +49% | +$9.95K |
|
1935
Shenandoah Telecom
SHEN
$632M
| $21.7K | ﹤0.01% |
1,408
+446
| +46% | +$5.83K |
|
1936
Mercury Insurance
MCY
$5.94B
| $21.7K | ﹤0.01% |
246
-24
| -9% | -$2.15K |
|
1937
Aurinia Pharmaceuticals
AUPH
$1.97B
| $21.6K | ﹤0.01% |
1,457
+215
| +17% | +$3.14K |
|
|
ARI
1938
Apollo Commercial Real Estate
ARI
$887M
| $21.3K | ﹤0.01% |
2,020
+267
| +15% | +$2.78K |
|
1939
Trevi Therapeutics
TRVI
$2.49B
| $21.3K | ﹤0.01% |
+1,784
| New | +$20K |
|
1940
Stoke Therapeutics
STOK
$1.82B
| $21.1K | ﹤0.01% |
648
+172
| +36% | +$5.64K |
|
1941
Alkami Technology
ALKT
$1.8B
| $21.1K | ﹤0.01% |
1,346
-133,059
| -99% | -$2.45M |
|
1942
Ivanhoe Electric
IE
$1.43B
| $20.7K | ﹤0.01% |
1,755
+293
| +20% | +$4.59K |
|
1943
Matsons
MATX
$6.37B
| $20.7K | ﹤0.01% |
126
+42
| +50% | +$6.53K |
|
1944
Cogent Communications
CCOI
$594M
| $20.5K | ﹤0.01% |
1,089
+215
| +25% | +$4.74K |
|
|
THR
1945
DELISTED
Thermon Group Holdings
THR
| $20.5K | ﹤0.01% |
406
+168
| +71% | +$7.83K |
|
1946
Madison Square Garden
MSGE
$3.61B
| $20.4K | ﹤0.01% |
346
+68
| +24% | +$4.02K |
|
1947
NeoGenomics
NEO
$1.81B
| $20.3K | ﹤0.01% |
2,740
+705
| +35% | +$7.42K |
|
1948
NETGEAR
NTGR
$669M
| $20.3K | ﹤0.01% |
929
+348
| +60% | +$7.51K |
|
1949
Collegium Pharmaceutical
COLL
$1.14B
| $20.2K | ﹤0.01% |
612
-8,354
| -93% | -$354K |
|
|
XNET
1950
Xunlei
XNET
$351M
| $20.1K | ﹤0.01% |
3,624
| – | – |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.